Bristol Myers Squibb is a global biopharmaceutical company with a history stretching back to 1887. It develops innovative medicines for serious diseases across key therapeutic areas including oncology, hematology, immunology, cardiology, and fibrosis. The company's portfolio includes transformational medicines and significant advances in cell therapy for patient care.
With approximately 32,500 employees worldwide, Bristol Myers Squibb maintains an operating presence in more than 100 countries. Its research and development operations are grounded in pharmaceutical science, immunotherapy, and cell therapy, alongside focused research programs in oncology, hematology, cardiology, and fibrosis.
The company describes its culture as combining the scale of a global biopharmaceutical leader with the entrepreneurial spirit of a biotech firm. Its commitment extends beyond medicine through the Bristol Myers Squibb Foundation, which promotes health equity and supports vulnerable populations globally.
